Document is current
Any future updates will be listed below
-
Authors
Homan, Rick A.
Lapek, John D.
Woo, Christina M.
Niessen, Sherry
Jones, Lyn H. https://orcid.org/0000-0002-8388-5865
Parker, Christopher G. https://orcid.org/0000-0001-8509-9289
- License Information
-
More Information
Article History
Accepted: 12 March 2024
First Online: 2 May 2024
Competing interests
: L.H.J. serves on the scientific advisory boards for, and holds equity in, Interline Therapeutics, Rapafusyn Pharmaceuticals, Ananke Therapeutics and Hyku Biosciences; consults for Matchpoint Therapeutics; holds equity in Jnana Therapeutics; and as the Director of the Center for Protein Degradation at DFCI receives research funding from Deerfield. The other authors declare no competing interests.
